Works in Cancer Chemotherapy & Pharmacology, 2007, Vol 59, Issue 2

Results: 19

Irinotecan changes gene expression in the small intestine of the rat with breast cancer.

Published in:

2007

By:

Bowen, Joanne M;
Gibson, Rachel J;
Cummins, Adrian G;
Tyskin, Anna;
Keefe, Dorothy M K

Publication type:

journal article

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer.

Published in:

2007

By:

Jeung, Hei-Cheul;
Rha, Sun Young;
Noh, Sung Hoon;
Roh, Jae Kyung;
Chung, Hyun Cheol

Publication type:

journal article

Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea.

Published in:

2007

By:

Hidaka, Muneaki;
Yamasaki, Keishi;
Okumura, Manabu;
Ogikubo, Tetsuya;
Iwakiri, Tomomi;
Setoguchi, Nao;
Nishida, Kentaro;
Nagai, Kimihiro;
Ikenoue, Tsuyomu;
Arimori, Kazuhiko

Publication type:

journal article

Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng.

Published in:

2007

By:

Aung, Han H;
Mehendale, Sangeeta R;
Wang, Chong Zhi;
Xie, Jing-Tian;
McEntee, Eryn;
Yuan, Chun-Su

Publication type:

journal article

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.

Published in:

2007

By:

Müller, Christine;
Gross, Dietmar;
Sarli, Vasiliki;
Gartner, Michael;
Giannis, Athanassios;
Bernhardt, Günther;
Buschauer, Armin;
Müller, Christine;
Bernhardt, Günther

Publication type:

journal article

Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 175, doi. 10.1007/s00280-006-0256-z

By:

Lu, Hongxia;
Li, Bin;
Kang, Yu;
Jiang, Wei;
Huang, Qian;
Chen, Qinghua;
Li, Limin;
Xu, Congjian

Publication type:

Article

An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 197, doi. 10.1007/s00280-006-0258-x

By:

Graham-Cole, Claire L.;
Thomas, Huw D.;
Taylor, Gordon A.;
Newell, David R.;
Melton, Roger G.;
Hesp, Richard;
Boddy, Alan V.

Publication type:

Article

Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 183, doi. 10.1007/s00280-006-0257-y

By:

Carter, Christopher A.;
Chen, Charles;
Brink, Cheryl;
Vincent, Patrick;
Maxuitenko, Yulia Y.;
Gilbert, Karen S.;
Waud, William R.;
Zhang, Xiaomei

Publication type:

Article

5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 227, doi. 10.1007/s00280-006-0261-2

By:

Islam, Shamima;
Hassan, Ferdaus;
Tumurkhuu, Gantsetseg;
Ito, Hiroyasu;
Koide, Naoki;
Mori, Isamu;
Yoshida, Tomoaki;
Yokochi, Takashi

Publication type:

Article

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.

Published in:

2007

By:

Schneider, Bryan;
Fukunaga, Anna;
Murry, Daryl;
Yoder, Christy;
Fife, Karen;
Foster, Anne;
Rosenberg, Leslie;
Kelich, Stephanie;
Li, Lang;
Sweeney, Christopher

Publication type:

journal article

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0

By:

Mita, Monica M.;
Rowinsky, Eric K.;
Forero, Leonardo;
Eckhart, S. Gail;
Izbicka, Elzbieta;
Weiss, Geoffrey R.;
Beeram, Muralidhar;
Mita, Alain C.;
de Bono, Johann S.;
Tolcher, Anthony W.;
Hammond, Lisa A.;
Simmons, Paul;
Berg, Kristin;
Takimoto, Chris;
Patnaik, Amita

Publication type:

Article

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.

Published in:

2007

By:

Losa, R.;
Fra, J.;
López-Pousa, A.;
Sierra, M.;
Goitia, A.;
Uña, E.;
Nadal, R.;
Muro, J. García del;
Gión, M.;
Maurel, J.;
Escudero, P.;
Esteban, E.;
Buesa, José M.;
López-Pousa, A;
Uña, E;
Del Muro, J García;
Gión, M;
Buesa, José M

Publication type:

journal article

Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 217, doi. 10.1007/s00280-006-0260-3

By:

Liu, Jingbo;
Li, Jing;
Sidell, Neil

Publication type:

Article

Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 275, doi. 10.1007/s00280-006-0269-7

By:

Abramjuk, Claudia;
Lein, Michael;
Rothaug, Winfried;
Krell, Hans-Willi;
Loening, Stefan A.;
Jung, Klaus

Publication type:

Article

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9

By:

Ma, Cynthia;
Mandrekar, Sumithra J.;
Alberts, Steven R.;
Croghan, Gary A.;
Jatoi, Aminah;
Reid, Joel M.;
Hanson, Lorelei J.;
Bruzek, Laura;
Tan, Angelina D.;
Pitot, Henry C.;
Erlichman, Charles;
Wright, John J.;
Adjei, Alex A.

Publication type:

Article

Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer.

Published in:

2007

By:

Seo, Jae Hong;
Oh, Sang Cheul;
Choi, Cheul Won;
Kim, Byung Soo;
Shin, Sang Won;
Kim, Yeul Hong;
Kim, Jun Suk;
Kim, Ae-Ree;
Lee, Jae-Bok;
Koo, Bum Hwan

Publication type:

journal article

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).

Published in:

2007

By:

Ryu, Jung Su;
Lee, Hong Sub;
Hong, Young-Soo;
Lee, Jung Joon;
Sohn, Uy Dong;
Kim, Tae Yong

Publication type:

Correction Notice

Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.

Published in:

2007

By:

Henley, D.;
Isbill, M.;
Fernando, R.;
Foster, J. S.;
Wimalasena, J.

Publication type:

journal article

Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 151, doi. 10.1007/s00280-006-0238-1

By:

Sugarbaker, Paul H.;
Stuart, O. Anthony

Publication type:

Article